Resistance and sensitivity observed in the three tested groups_
| Group* | Sensitivity Number of cases (%) | Resistance Number of cases (%) | |
|---|---|---|---|
| Group 1 (AL-Bendazol 2.5%) | 2 (13.33%) | 13 (86.67%) | |
| Group 2 (Valbazen) | 5 (33.33%) | 10 (66,67%) | |
| Group 3 (Oxfenil 2.265%) | 2 (13.33%) | 13 (86.67%) | |
| p-value | |||
| (1 vs 2) | 0.344 | 0.874 | 0.591 |
| (1 vs 3) | 0.454 | 0.439 | 0.551 |
| (2 vs 3) | 0.069 | 0.507 | 0.283 |
The Faecal egg count reduction and the number of eggs per gram of faeces (before and after treatment)_
| Group* | Group 1 | Group 2 | Group3 | |
|---|---|---|---|---|
| EPG1 | Average ± SD | 803.3 ± 329.8 | 450 ± 275.2 | 353.3 ± 246.7 |
| Range (Mini – Max) | 150 – 1600 | 150 – 1050 | 150 – 1150 | |
| EPG2 | Average ± SD | 96.7 ± 66.7 | 50.0 ± 50.0 | 86.7 ± 71.2 |
| Range (Mini – Max) | 0 – 250 | 0 – 150 | 0 – 250 | |
| FECR1(%) S | Average ± SD | 100 ± 0 | 100 ± 0 | 100 ± 0 |
| Range (Mini – Max) | 100 – 100 | 100 – 100 | 100 – 100 | |
| Number of cases | 2 | 5 | 2 | |
| FECR2 (%) R | Average ± SD | 85.7 ± 7.1 | 81.9 ± 9.1 | 69.5 ± 19.0 |
| Range (Mini – Max) | 70.6 – 94.1 | 66.7 – 94.1 | 16.7 – 91.3 | |
| Number of cases | 13 | 10 | 13 | |